Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec;15(12):730-4.
doi: 10.3779/j.issn.1009-3419.2012.12.07.

[Correlation between regional node metastasis and imageological characteristics in non-small cell lung cancer]

[Article in Chinese]
Minggang Su  1 , Lin Li
Affiliations

[Correlation between regional node metastasis and imageological characteristics in non-small cell lung cancer]

[Article in Chinese]
Minggang Su et al. Zhongguo Fei Ai Za Zhi. 2012 Dec.

Abstract
in English, Chinese

N staging is a key factor for the choice of treatment modalities in patients with non-small cell lung cancer. Both of the noninvasive and invasive N staging procedures have their own limitations. It is reported that some imageological characteristics have predictive value, including tumor size, CT attenuation and fluorodeoxyglucose (FDG) standardized uptake value (SUV), and so on. It is expected to find the key risk factors with multivariate analysis.

非小细胞肺癌（non-small cell lung cancer, NSCLC）局部淋巴结（N）分期是影响患者治疗方案选择的关键因素之一。目前临床所使用的无创和有创性N分期方法均有其局限性。研究发现NSCLC的某些影像学特点可预测淋巴结转移的危险性，包括大小、CT密度和氟代脱氧葡萄糖（fluorodeoxyglucose, FDG）标准化摄取值（standardized uptake value, SUV）等。期待系统性多因素分析，以发现影响肺癌淋巴结转移的关键因素。

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Jemal A, Center MM, Desantis C, et al. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010;19(8):1893–1907. doi: 10.1158/1055-9965.EPI-10-0437. - DOI - PubMed
    1. D' Addario G, Felip E, ESMO Guidelines Working Group Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009;20(Suppl 4):68–70. - PubMed

    1. NCCN clinical practice guidelines in oncology: non-small cell lung cancer, Version 3. 2012. [2012. 10. 13] http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf.

    1. Silvestri GA, Gould MK, Margolis ML, et al. Noninvasive staging of non-small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition) https://www.sciencedirect.com/science/article/pii/S0012369215355197. Chest. 2007;132(3 Suppl):178S–201S. - PubMed
    1. de Langen AJ, Raijmakers P, Riphagen I, et al. The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis. Eur J Cardiothorac Surg. 2006;29(1):26–29. doi: 10.1016/j.ejcts.2005.10.002. - DOI - PubMed

Substances